8th & 9th March, 2023, Brussels Our CEO Eva Kováčová is one of the organisers of the first summit by the EU Female Founders in Brussels under the sponsorship of
Glycanostics took another important step to improve its quality management system and has been granted with ISO 13485.
Glycanostics was selected as one of eight most innovative companies to participate in the MEDICAL FORGE Accelerator program 2023, which will facilitate and accelerate our entry to the German market.
Glycanostics was invited to attend the EIC Summit that took place on 7th and 8th December in Brussels. We have spent two days learning about the vision of the EIC
Glycanostics was honoured to be invited for the EIC Corporate Day with Medtronic and Fresenius Kabi in November 2022. We presented our innovative approach to cancer diagnostics and had very
Glycanostics, Ltd. hosted an important visit – 17 ambassadors from different countries from Asia, Europe, South America and USA. We introduced them our company, explained the challenges of current cancer diagnostics
Europe’s largest biotech partnering conference Bio Europe brings together key players in biotech industry, key decision-makers, most innovative companies and Glycanostics was among them. We established several useful contacts and
Glycanostics, Ltd. as a regional winner, was selected from more than 10 000 start-ups around the world to attend and compete at Startup World Cup 2022 in San Francisco.
Glycanostics was invited to attend 1st Pan-European Hospital and Healthcare Procurement Summit in Brussels as a recipient of EIC Accelerator grant. We presented our solutions for early cancer diagnostics, monitoring and
